Henalog Tablet contains Alpha Ketoanalogue (NA), a therapeutic agent primarily used as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, aiding in the reduction of nitrogenous waste accumulation and alleviating the metabolic burden on compromised renal function. This medication is indicated for patients with CKD stages 3 to 5, particularly those undergoing protein-restricted diets, to help maintain nutritional status while minimizing uremic toxin production. Henalog Tablet facilitates the synthesis of essential amino acids through transamination, thereby supporting protein metabolism without increasing nitrogen load. It is typically administered as part of a comprehensive renal diet and treatment regimen under medical supervision. The use of Alpha Ketoanalogue has been shown to slow the progression of renal impairment and delay the need for dialysis by improving metabolic parameters and reducing azotemia. Adverse effects are generally minimal but may include gastrointestinal disturbances or allergic reactions in sensitive individuals. Henalog Tablet should be used cautiously in patients with hepatic impairment or those with known hypersensitivity to its components. Regular monitoring of renal function, nutritional status, and metabolic parameters is recommended during therapy to optimize clinical outcomes.